» Articles » PMID: 35246761

Low H3K27 Acetylation of SF1 in PBMC: a Biomarker for Prenatal Dexamethasone Exposure-caused Adrenal Insufficiency of Steroid Synthesis in Male Offspring

Overview
Publisher Springer
Specialties Cell Biology
Toxicology
Date 2022 Mar 5
PMID 35246761
Authors
Affiliations
Soon will be listed here.
Abstract

Dexamethasone is widely used to treat pregnancy disorders related to premature delivery. However, lots of researches have confirmed that prenatal dexamethasone exposure (PDE) could increase the risk of offspring multiple diseases. This study was designed to elucidate the epigenetic mechanism of adrenal developmental programming and explore its early warning marker in peripheral blood mononuclear cells (PBMC). We found the adrenal morphological and functional changes of PDE male offspring rats before and after birth, which were mainly performed as the decreased serum corticosterone concentration, steroidogenic acute regulatory (StAR) protein expression, and histone 3 lysine 27 acetylation (H3K27ac) level of steroidogenic factor 1 (SF1) promoter region and its expression. Simultaneously, the expressions of glucocorticoid receptor (GR) and histone acetylation enzyme 5 (HDAC5) in the PDE male fetal rats were increased. In vitro, dexamethasone reduced the expression of SF1, StAR, and cortisol production and still increased the expression of GR and HDAC5, the binding between GR and SF1 promoter region, and protein interaction between GR and HDAC5. GR siRNA or HDAC5 siRNA was able to reverse the above roles of dexamethasone. Furthermore, in vivo, we confirmed that H3K27ac levels of SF1 promoter region and its expression in PBMC of the PDE group were decreased before and after birth, showing a positive correlation with the same indexes in adrenal. Meanwhile, in clinical trials, we confirmed that prenatal dexamethasone application decreased H3K27ac of SF1 promoter region and its expression in neonatal PBMC. In conclusion, PDE-caused adrenal insufficiency of male offspring rats was related to adrenal GR activated by dexamethasone in uterus. The activated GR, on the one hand, increased its direct binding to SF1 promoter region to inhibit its expression, on the other hand, upregulated and recruited HDAC5 to decrease H3K27ac level of SF1 promoter region, and strengthened the inhibition of SF1 and subsequent StAR expression.

Citing Articles

Prenatal dexamethasone exposure impairs rat blood-testis barrier function and sperm quality in adult offspring via GR/KDM1B/FSTL3/TGFβ signaling.

Liu Y, Chen S, Ai C, Yu P, Fang M, Wang H Acta Pharmacol Sin. 2024; 45(6):1237-1251.

PMID: 38472317 PMC: 11130295. DOI: 10.1038/s41401-024-01244-5.


Contribution of changes in the orexin system and energy sensors in the brain in depressive disorder - a study in an animal model.

Glombik K, Kukla-Bartoszek M, Curzytek K, Basta-Kaim A, Budziszewska B Pharmacol Rep. 2024; 76(1):51-71.

PMID: 38194217 PMC: 10830606. DOI: 10.1007/s43440-023-00559-0.


Transgenerational inheritance of adrenal steroidogenesis inhibition induced by prenatal dexamethasone exposure and its intrauterine mechanism.

He Z, Zhang J, Chen Y, Ai C, Gong X, Xu D Cell Commun Signal. 2023; 21(1):294.

PMID: 37853416 PMC: 10585925. DOI: 10.1186/s12964-023-01303-0.


The Dysregulation of SOX Family Correlates with DNA Methylation and Immune Microenvironment Characteristics to Predict Prognosis in Hepatocellular Carcinoma.

Qin S, Liu G, Jin H, Chen X, He J, Xiao J Dis Markers. 2022; 2022:2676114.

PMID: 35465267 PMC: 9020970. DOI: 10.1155/2022/2676114.

References
1.
Chawanpaiboon S, Vogel J, Moller A, Lumbiganon P, Petzold M, Hogan D . Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob Health. 2018; 7(1):e37-e46. PMC: 6293055. DOI: 10.1016/S2214-109X(18)30451-0. View

2.
Vogel J, Souza J, Gulmezoglu A, Mori R, Lumbiganon P, Qureshi Z . Use of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the WHO Multicountry Survey on Maternal and Newborn Health. Lancet. 2014; 384(9957):1869-1877. DOI: 10.1016/S0140-6736(14)60580-8. View

3.
Asztalos E, Murphy K, Hannah M, Willan A, Matthews S, Ohlsson A . Multiple courses of antenatal corticosteroids for preterm birth study: 2-year outcomes. Pediatrics. 2010; 126(5):e1045-55. DOI: 10.1542/peds.2010-0857. View

4.
Elfayomy A, Almasry S . Effects of a single course versus repeated courses of antenatal corticosteroids on fetal growth, placental morphometry and the differential regulation of vascular endothelial growth factor. J Obstet Gynaecol Res. 2014; 40(11):2135-45. DOI: 10.1111/jog.12466. View

5.
Xu D, Chen M, Pan X, Xia L, Wang H . Dexamethasone induces fetal developmental toxicity through affecting the placental glucocorticoid barrier and depressing fetal adrenal function. Environ Toxicol Pharmacol. 2011; 32(3):356-63. DOI: 10.1016/j.etap.2011.08.003. View